220 related articles for article (PubMed ID: 11019857)
1. An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.
Fezoui Y; Hartley DM; Harper JD; Khurana R; Walsh DM; Condron MM; Selkoe DJ; Lansbury PT; Fink AL; Teplow DB
Amyloid; 2000 Sep; 7(3):166-78. PubMed ID: 11019857
[TBL] [Abstract][Full Text] [Related]
2. Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.
Bozso Z; Penke B; Simon D; Laczkó I; Juhász G; Szegedi V; Kasza A; Soós K; Hetényi A; Wéber E; Tóháti H; Csete M; Zarándi M; Fülöp L
Peptides; 2010 Feb; 31(2):248-56. PubMed ID: 19995586
[TBL] [Abstract][Full Text] [Related]
3. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.
Lomakin A; Chung DS; Benedek GB; Kirschner DA; Teplow DB
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1125-9. PubMed ID: 8577726
[TBL] [Abstract][Full Text] [Related]
4. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
Shen CL; Fitzgerald MC; Murphy RM
Biophys J; 1994 Sep; 67(3):1238-46. PubMed ID: 7811938
[TBL] [Abstract][Full Text] [Related]
5. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
7. Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.
Shen CL; Scott GL; Merchant F; Murphy RM
Biophys J; 1993 Dec; 65(6):2383-95. PubMed ID: 8312477
[TBL] [Abstract][Full Text] [Related]
8. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
9. Conformational restriction via cyclization in beta-amyloid peptide Abeta(1-28) leads to an inhibitor of Abeta(1-28) amyloidogenesis and cytotoxicity.
Kapurniotu A; Buck A; Weber M; Schmauder A; Hirsch T; Bernhagen J; Tatarek-Nossol M
Chem Biol; 2003 Feb; 10(2):149-59. PubMed ID: 12618187
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the aggregation propensity of the β -amyloid peptide during the synthesis and when free in solution.
Malavolta L; Pinto MR; Nakaie CR
Protein Pept Lett; 2013 Aug; 20(8):848-55. PubMed ID: 23458076
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's amyloid fibrils: structure and assembly.
Serpell LC
Biochim Biophys Acta; 2000 Jul; 1502(1):16-30. PubMed ID: 10899428
[TBL] [Abstract][Full Text] [Related]
12. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
13. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE
Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285
[TBL] [Abstract][Full Text] [Related]
14. Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates.
Qahwash I; Weiland KL; Lu Y; Sarver RW; Kletzien RF; Yan R
J Biol Chem; 2003 Jun; 278(25):23187-95. PubMed ID: 12684519
[TBL] [Abstract][Full Text] [Related]
15. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.
Pike CJ; Overman MJ; Cotman CW
J Biol Chem; 1995 Oct; 270(41):23895-8. PubMed ID: 7592576
[TBL] [Abstract][Full Text] [Related]
16. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
Ohnishi S; Koide A; Koide S
J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
18. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
20. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
